Global  

No evidence of benefit for chloroquine and hydroxychloroquine in COVID-19 patients, study finds

Science Daily Friday, 22 May 2020 ()
A new study finds that the use of chloroquine or hydroxychloroquine is linked to increased rates of mortality and heart arrhythmias among hospital patients with COVID-19. The authors suggest that these drug regimens should not be used to treat COVID-19 outside of clinical trials and urgent confirmation from randomised clinical trials is needed.
0
shares
ShareTweetSavePostSend
 
Credit: Wochit - Published
News video: Chloroquine And Hydroxychloroquine Could Pose Higher COVID-19 Death Risk

Chloroquine And Hydroxychloroquine Could Pose Higher COVID-19 Death Risk 00:35

According to UPI, chloroquine and hydroxychloroquine has no clinical benefit for people with COVID-19. A study published in The Lancet on Friday says that the drugs might actually cause serious heart-related side effects. The study of 15,000 patients found increased rate of heart-related side...

You Might Like


Related videos from verified sources

WHO Puts The Brakes On Hydroxychloroquine Trials [Video]

WHO Puts The Brakes On Hydroxychloroquine Trials

The World Health Organization is pausing clinical trials of hydroxychloroquine as a possible treatment for the novel coronavirus COVID-19. According to Business Insider, the WHO's steering committee..

Credit: Wochit     Duration: 00:36Published
Large Scale UK Study Highlights Major Risk Factors In Dying From COVID-19 [Video]

Large Scale UK Study Highlights Major Risk Factors In Dying From COVID-19

The results of the largest study to date of coronavirus patients outside China was published Friday. According to Business Insider, researchers analyzed data from 20,133 patients hospitalized across..

Credit: Wochit     Duration: 00:35Published

Tweets about this